Evidence map›Paper›PMID 26732475›Full record

ArticleMedical oncology (Northwood, London, England)2016

27-Hydroxycholesterol stimulates cell proliferation and resistance to docetaxel-induced apoptosis in prostate epithelial cells.

Shaneabbas Raza, Megan Meyer, Jared Schommer, Kimberly D P Hammer, Bin Guo, Othman Ghribi

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 41 citations in OpenAlex.

  1. 27-Hydroxycholesterol in cancer development and drug resistance.Journal of enzyme inhibition and medicinal chemistry · 2025
    Review
  2. The vitamin DAmerican journal of physiology. Cell physiology · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Oxysterols as Biomarkers of Aging and Disease.Advances in experimental medicine and biology · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. MITOCHONDRIAL CHOLESTEROL AND CANCER.Seminars in cancer biology · 2021
    Review
  11. Obesity and Cancer: 27-Hydroxycholesterol, the Missing Link.International journal of molecular sciences · 2020
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. The Role of Oxysterols in Human Cancer.Trends in endocrinology and metabolism: TEM · 2017
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Shaneabbas RazaDepartment of Basic Sciences, University of North Dakota School of Medicine and Health Sciences, 501 North Columbia Road, Grand Forks, ND, 58202, USA.
Megan MeyerDepartment of Basic Sciences, University of North Dakota School of Medicine and Health Sciences, 501 North Columbia Road, Grand Forks, ND, 58202, USA.
Jared SchommerDepartment of Basic Sciences, University of North Dakota School of Medicine and Health Sciences, 501 North Columbia Road, Grand Forks, ND, 58202, USA.
Kimberly D P HammerDepartment of Veteran Affairs, Fargo VA Health Care System, Fargo, ND, 58102, USA.
Bin GuoDepartment of Pharmaceutical Sciences, North Dakota State University, Fargo, ND, 58108, USA.
Othman GhribiDepartment of Basic Sciences, University of North Dakota School of Medicine and Health Sciences, 501 North Columbia Road, Grand Forks, ND, 58202, USA. othman.ghribi@med.und.edu.
University of North Dakota · USFargo VA Health Care System · USNorth Dakota State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the causes of prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are not known, the role of oxidative stress, aging, and diet are suspected to increase the incidence of prostate complications. The cholesterol oxidation derivative (oxysterol) 27-hydroxycholesterol (27-OHC) is the most prevalent cholesterol metabolite in the blood. As aging, oxidative stress, and hypercholesterolemia are associated with increased risk of PCa and BPH, and because 27-OHC levels are also increased with aging, hypercholesterolemia, and oxidative stress, determining the role of 27-OHC in the progression of PCas and BPH is warranted. In this study, we determined the effect of 27-OHC in human prostate epithelial cells RWPE-1. We found that 27-OHC stimulates proliferation and increases androgen receptor (AR) transcriptional activity. 27-OHC also increased prostate-specific antigen expression and enhanced AR binding to the androgen response element compared to controls. Silencing AR expression with siRNA markedly reduced the 27-OHC-induced proliferation. Furthermore, 27-OHC blocked docetaxel-induced apoptosis. Altogether, our results suggest that 27-OHC may play an important role in PCa and BPH progression by promoting proliferation and suppressing apoptosis.

Indexed as

Antineoplastic AgentsApoptosisCell ProliferationCells, CulturedDocetaxelDrug Resistance, NeoplasmEpithelial CellsHumansHydroxycholesterolsKallikreinsMalePromoter Regions, GeneticProstateProstate-Specific AntigenReceptors, AndrogenTaxoids27-hydroxycholesterolAntineoplastic AgentsDocetaxelHydroxycholesterolsKallikreinsKLK3 protein, humanProstate-Specific AntigenReceptors, AndrogenTaxoids27-HydroxycholesterolAndrogen receptorBenign prostatic hyperplasiaProliferationProstate cancer

Identifiers

PMID26732475
OpenAlexW2222684049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.